ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,194Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 2035

$1.05M Total Retail Price of All Prescriptions

Rank: 42 out of 2035

664 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 664 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 664 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,766 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 1,241 592 1 1
LISINOPRIL 864 464 2 3
LEVOTHYROXINE SODIUM 752 342 3 4
OMEPRAZOLE 700 282 4 5
AMLODIPINE BESYLATE 552 339 5 6
METFORMIN HCL 455 250 6 9
METOPROLOL TARTRATE 390 224 7 8
ATENOLOL 323 228 8 10
ATORVASTATIN CALCIUM 317 146 9 13
HYDROCODONE-ACETAMINOPHEN 292 163 S3 10 2
PROAIR HFA 272 42 11 31
FUROSEMIDE 249 192 12 7
SPIRIVA 223 87 13 44
TAMSULOSIN HCL 203 83 14 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 197 127 15 26
ALENDRONATE SODIUM 183 105 16 27
ZOLPIDEM TARTRATE 180 98 17 21
POTASSIUM CHLORIDE 170 137 18 18
TRAMADOL HCL 163 91 19 19
VENTOLIN HFA 162 33 20 80
MELOXICAM 153 79 21 56
LOVASTATIN 150 54 22 33
GABAPENTIN 147 44 23 14
WARFARIN SODIUM 142 104 24 11
NEXIUM 142 16 24 51
CARVEDILOL 134 68 26 22
ADVAIR DISKUS 134 30 26 38
CITALOPRAM HBR 130 122 28 20
AZITHROMYCIN 129 76 29 39
LOSARTAN POTASSIUM 128 85 30 15
POLYETHYLENE GLYCOL 3350 126 48 31 48
PHENYTOIN SODIUM EXTENDED 121 30 32 132
FLUTICASONE PROPIONATE 121 28 32 29
DONEPEZIL HCL 120 108 34 24
RANITIDINE HCL 120 40 34 28
ISOSORBIDE MONONITRATE ER 116 63 36 32
RISPERIDONE 110 35 37 68
METFORMIN HCL ER 110 75 37 78
CLONIDINE HCL 108 49 39 61
FLOVENT HFA 108 22 39 238
HYDROCHLOROTHIAZIDE 108 49 39 12
HYDROCORTISONE 107 51 42 156
PROPRANOLOL HCL 100 62 43 161
LANTUS 100 30 43 40
QVAR 92 34 45 234
CLOPIDOGREL 92 55 45 30
OXYBUTYNIN CHLORIDE 91 20 47 102
FAMOTIDINE 87 72 48 71
INSULIN SYRINGE 86 21 49 97
PRAVASTATIN SODIUM 83 39 50 17
DILTIAZEM 24HR ER 81 58 51 143
ABILIFY 76 39 52 174
NIFEDIPINE ER 76 47 52 98
CYMBALTA 76 19 52 59
LANTUS SOLOSTAR 75 48 55 66
METOPROLOL SUCCINATE 74 45 56 16
TRAZODONE HCL 73 31 57 50
SERTRALINE HCL 72 43 58 23
TOVIAZ 71 34 59 420
LEVETIRACETAM 71 16 59 87
FINASTERIDE 69 52 61 105
LOVAZA 67 0 62 137
ATENOLOL-CHLORTHALIDONE 66 55 63 179
CRESTOR 65 0 64 41
GLIMEPIRIDE 65 33 64 55
PEN NEEDLE 65 44 64 100
PLAVIX 65 42 64 49
LOSARTAN-HYDROCHLOROTHIAZIDE 63 63 68 47
XOPENEX HFA 60 12 69 375
DETROL LA 59 14 70 237
OLANZAPINE 59 35 70 121
GLIPIZIDE 56 45 72 54
BACLOFEN 56 0 72 112
KETOCONAZOLE 56 27 72 215
AMITRIPTYLINE HCL 55 31 R 75 101
VESICARE 55 14 75 209
MIRTAZAPINE 55 25 75 46
LIPITOR 55 22 75 134
ALLOPURINOL 54 42 79 34
COMBIVENT 54 25 79 154
DOXYCYCLINE HYCLATE 53 27 81 129
DIGOXIN 50 18 82 67
TRIAMTERENE-HCTZ 50 37 82 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 31, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.